What's Happening?
Novartis Malaysia has been awarded in the Digital - Pharmaceuticals category at the Malaysia Technology Excellence Awards 2026 for its AI-driven transformation of Source to Pay enquiry management. The award highlights the company's commitment to advancing
smarter, more intuitive ways of working through technology. At the core of this achievement is an AI-enabled virtual assistant that integrates multilingual support, real-time enterprise resource planning insights, and live agent assistance. This solution simplifies support for employees, enabling them to resolve procurement-related queries more efficiently. The virtual assistant provides guidance in over 120 languages, supporting a diverse global workforce.
Why It's Important?
The recognition of Novartis Malaysia's AI solution underscores the growing importance of digital innovation in the pharmaceutical industry. By streamlining procurement processes, the company enhances operational efficiency, allowing employees to focus on higher-value tasks. This technological advancement not only improves internal processes but also supports the timely delivery of medicines, ultimately benefiting patients. The successful implementation of this AI solution in Malaysia and its expansion to other international markets demonstrate the potential for significant impact beyond local borders.
What's Next?
Following its success in Malaysia, the AI-powered Source to Pay chatbot is being introduced across other international markets. This expansion reflects the strength of the solution and the calibre of local talent behind it. As the company continues to roll out this technology globally, it may set a precedent for other pharmaceutical companies to adopt similar innovations, further driving digital transformation in the industry.
